The Asia Pacific Smart Inhalers Market would witness market growth of 27.1% CAGR during the forecast period (2021-2027).
Smart inhalers are predicted to improve patients’ adherence to conventional inhalers. Patients' unintentional non-adherence occurs when they misinterpret instructions, forget, or have physiological problems, such as poor coordination or vision, limiting their ability to take their medications. The smart inhaler industry is a fairly competitive one due to multiple collaborations, partnerships, and acquisitions among pharmaceutical companies and smart inhaler producers. Additionally, the rise in healthcare expenditure in developing economies presents hugely profitable opportunities for the market and therefore offers suitable conditions for key players to invest.
Smart inhalers monitor and communicate data about inhaler use. Smart inhalers have sensors that attach to existing inhalers and keep track of when a patient takes their prescription. They are Bluetooth-enabled and may be connected wirelessly with a smart device such as a phone or tablet, as well as a computer, to automatically upload data from the smart inhaler. An app on a smartphone could receive and analyze data from a smart inhaler in the future, and send health advice and reminders. This information may also be shared with the doctor, asthma nurse, or hospital staff in order to better personalize care to their specific requirements. Recognizing when and where particular symptoms flare up might help patients identify personal triggers and create a self-management plan that is more suited to them.
Due to the increasing number of suppliers penetrating the untapped emerging Asian economies, the market in the Asia Pacific is expected to rise at a lucrative rate. Additionally, increasing spending on healthcare IT development in emerging countries will fuel regional expansion. India's healthcare system is still developing, but it has a lot of potential, making it a very attractive market for smart inhalers. As a rising economy, India is witnessing significant industrialization and urbanization, which has increased pollution levels in the country and, as a result, increased respiratory disease cases. Asthma incidences have increased dramatically, resulting in a significant demand for asthma inhalers across the country. In addition, the country's elderly population is growing, putting more people at risk of respiratory problems. All of these reasons add up to a very profitable market for smart inhalers in India. As more people become aware of smart inhalers and their benefits become clear, product adoption in India is projected to skyrocket.
The China market dominated the Asia Pacific Smart Inhalers Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $33,826 Thousands by 2027. The Japan market is poised to grow at a CAGR of 26.4% during (2021 - 2027). Additionally, The India market would experience a CAGR of 27.9% during (2021 - 2027).
Based on Product, the market is segmented into Metered Dose Inhalers (MDI's), and Dry Powdered Inhalers (DPIs). Based on Disease Indication, the market is segmented into Asthma, and Chronic Obstructive Pulmonary Disease (COPD). Based on Distribution Channel, the market is segmented into Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Smart Inhalers Market is Projected to reach USD 414.4 Million by 2027, at a CAGR of 24.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Adherium Limited, Aptar Group Inc. (Cohero Health Inc.), AstraZeneca, Inc., Cognita Labs, LLC, GlaxoSmithKline Plc, Novartis AG, OPKO Health, Inc., Philip Morris International, Inc. (Vectura Group Plc), Resmed, Inc. (Propeller Health), and Teva Pharmaceutical Industries Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Metered Dose Inhalers (MDI's)
- Dry Powdered Inhalers (DPIs)
By Disease Indication
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Adherium Limited
- Aptar Group Inc. (Cohero Health Inc.)
- AstraZeneca, Inc.
- Cognita Labs, LLC
- GlaxoSmithKline Plc
- Novartis AG
- OPKO Health, Inc.
- Philip Morris International, Inc. (Vectura Group Plc)
- Resmed, Inc. (Propeller Health)
- Teva Pharmaceutical Industries Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Smart Inhalers Market, by Product
1.4.2 Asia Pacific Smart Inhalers Market, by Disease Indication
1.4.3 Asia Pacific Smart Inhalers Market, by Distribution Channel
1.4.4 Asia Pacific Smart Inhalers Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
Chapter 4. Asia Pacific Smart Inhalers Market by Product
4.1 Asia Pacific Metered Dose Inhalers (MDI's) Market by Country
4.2 Asia Pacific Dry Powdered Inhalers (DPIs) Market by Country
Chapter 5. Asia Pacific Smart Inhalers Market by Disease Indication
5.1 Asia Pacific Asthma Market by Country
5.2 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Market by Country
Chapter 6. Asia Pacific Smart Inhalers Market by Distribution Channel
6.1 Asia Pacific Hospitals Pharmacies Market by Country
6.2 Asia Pacific Retail Pharmacies Market by Country
6.3 Asia Pacific Online Pharmacies Market by Country
Chapter 7. Asia Pacific Smart Inhalers Market by Country
7.1 China Smart Inhalers Market
7.1.1 China Smart Inhalers Market by Product
7.1.2 China Smart Inhalers Market by Disease Indication
7.1.3 China Smart Inhalers Market by Distribution Channel
7.2 Japan Smart Inhalers Market
7.2.1 Japan Smart Inhalers Market by Product
7.2.2 Japan Smart Inhalers Market by Disease Indication
7.2.3 Japan Smart Inhalers Market by Distribution Channel
7.3 India Smart Inhalers Market
7.3.1 India Smart Inhalers Market by Product
7.3.2 India Smart Inhalers Market by Disease Indication
7.3.3 India Smart Inhalers Market by Distribution Channel
7.4 South Korea Smart Inhalers Market
7.4.1 South Korea Smart Inhalers Market by Product
7.4.2 South Korea Smart Inhalers Market by Disease Indication
7.4.3 South Korea Smart Inhalers Market by Distribution Channel
7.5 Singapore Smart Inhalers Market
7.5.1 Singapore Smart Inhalers Market by Product
7.5.2 Singapore Smart Inhalers Market by Disease Indication
7.5.3 Singapore Smart Inhalers Market by Distribution Channel
7.6 Malaysia Smart Inhalers Market
7.6.1 Malaysia Smart Inhalers Market by Product
7.6.2 Malaysia Smart Inhalers Market by Disease Indication
7.6.3 Malaysia Smart Inhalers Market by Distribution Channel
7.7 Rest of Asia Pacific Smart Inhalers Market
7.7.1 Rest of Asia Pacific Smart Inhalers Market by Product
7.7.2 Rest of Asia Pacific Smart Inhalers Market by Disease Indication
7.7.3 Rest of Asia Pacific Smart Inhalers Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Adherium Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Approvals and Trials:
8.2 GlaxoSmithKline PLC (GSK)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Teva Pharmaceutical Industries Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 AstraZeneca PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.5 OPKO Health, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.6 Aptar Group, Inc. (Cohero Health Inc.)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.7 Novartis AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Approvals and Trials:
8.8 ResMed, Inc. (Propeller Health)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Acquisition and Mergers:
8.9 Cognita Labs, LLC
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Approvals and Trials:
8.10. Vectura Group plc (Philip Morris International, Inc.)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
TABLE 1 Asia Pacific Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 2 Asia Pacific Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 3 Partnerships, Collaborations and Agreements– Smart Inhalers Market
TABLE 4 Product Launches And Product Expansions– Smart Inhalers Market
TABLE 5 Acquisition and Mergers– Smart Inhalers Market
TABLE 6 Approvals and trials- smart inhalers market
TABLE 7 Asia Pacific Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 8 Asia Pacific Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 9 Asia Pacific Metered Dose Inhalers (MDI's) Market by Country, 2017 - 2020, USD Thousands
TABLE 10 Asia Pacific Metered Dose Inhalers (MDI's) Market by Country, 2021 - 2027, USD Thousands
TABLE 11 Asia Pacific Dry Powdered Inhalers (DPIs) Market by Country, 2017 - 2020, USD Thousands
TABLE 12 Asia Pacific Dry Powdered Inhalers (DPIs) Market by Country, 2021 - 2027, USD Thousands
TABLE 13 Asia Pacific Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 14 Asia Pacific Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 15 Asia Pacific Asthma Market by Country, 2017 - 2020, USD Thousands
TABLE 16 Asia Pacific Asthma Market by Country, 2021 - 2027, USD Thousands
TABLE 17 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2017 - 2020, USD Thousands
TABLE 18 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2021 - 2027, USD Thousands
TABLE 19 Asia Pacific Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 20 Asia Pacific Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 21 Asia Pacific Hospitals Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 22 Asia Pacific Hospitals Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 23 Asia Pacific Retail Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 24 Asia Pacific Retail Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 25 Asia Pacific Online Pharmacies Market by Country, 2017 - 2020, USD Thousands
TABLE 26 Asia Pacific Online Pharmacies Market by Country, 2021 - 2027, USD Thousands
TABLE 27 Asia Pacific Smart Inhalers Market by Country, 2017 - 2020, USD Thousands
TABLE 28 Asia Pacific Smart Inhalers Market by Country, 2021 - 2027, USD Thousands
TABLE 29 China Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 30 China Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 31 China Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 32 China Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 33 China Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 34 China Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 35 China Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 36 China Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 37 Japan Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 38 Japan Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 39 Japan Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 40 Japan Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 41 Japan Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 42 Japan Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 43 Japan Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 44 Japan Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 45 India Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 46 India Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 47 India Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 48 India Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 49 India Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 50 India Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 51 India Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 52 India Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 53 South Korea Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 54 South Korea Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 55 South Korea Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 56 South Korea Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 57 South Korea Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 58 South Korea Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 59 South Korea Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 60 South Korea Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 61 Singapore Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 62 Singapore Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 63 Singapore Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 64 Singapore Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 65 Singapore Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 66 Singapore Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 67 Singapore Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 68 Singapore Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 69 Malaysia Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 70 Malaysia Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 71 Malaysia Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 72 Malaysia Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 73 Malaysia Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 74 Malaysia Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 75 Malaysia Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 76 Malaysia Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 77 Rest of Asia Pacific Smart Inhalers Market, 2017 - 2020, USD Thousands
TABLE 78 Rest of Asia Pacific Smart Inhalers Market, 2021 - 2027, USD Thousands
TABLE 79 Rest of Asia Pacific Smart Inhalers Market by Product, 2017 - 2020, USD Thousands
TABLE 80 Rest of Asia Pacific Smart Inhalers Market by Product, 2021 - 2027, USD Thousands
TABLE 81 Rest of Asia Pacific Smart Inhalers Market by Disease Indication, 2017 - 2020, USD Thousands
TABLE 82 Rest of Asia Pacific Smart Inhalers Market by Disease Indication, 2021 - 2027, USD Thousands
TABLE 83 Rest of Asia Pacific Smart Inhalers Market by Distribution Channel, 2017 - 2020, USD Thousands
TABLE 84 Rest of Asia Pacific Smart Inhalers Market by Distribution Channel, 2021 - 2027, USD Thousands
TABLE 85 Key Information – Adherium Limited
TABLE 86 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 87 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 88 KEY INFORMATION – ASTRAZENECA PLC
TABLE 89 Key Information – OPKO Health, Inc.
TABLE 90 key Information – Aptar Group, Inc.
TABLE 91 Key Information – Novartis AG
TABLE 92 Key Information – ResMed, Inc.
TABLE 93 Key Information – Cognita Labs, LLC
TABLE 94 Key Information – Vectura Group plc
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Recent strategies and developments: Adherium Limited
FIG 4 Recent strategies and developments: AptarGroup, Inc.